Skip to main content

A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect ofEDG-5506 on Safety, Biomarkers, Pharmacokinetics, and Functional Measures in Adults andAdolescents with Becker Muscular Dystrophy

Open
  • Protocol code: EDG-5506-201
  • EudraCT code: No aplica
  • Research group: Peripheral Nervous System
  • Service: Neurology
  • Principal investigator:  Juntas Morales, Raul
  • Phase: Fase II
  • Status: Recruiting volunteers